Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface

Seok Ki Choi, Andrzej Myc, Justin Ezekiel Silpe, Madhuresh Sumit, Pamela Tinmoi Wong, Kelly McCarthy, Ankur M. Desai, Thommey P. Thomas, Alina Kotlyar, Mark M. Banaszak Holl, Bradford G. Orr, James R. Baker

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Vancomycin represents the preferred ligand for bacteria-targeting nanosystems. However, it is inefficient for emerging vancomycin-resistant species because of its poor affinity to the reprogrammed cell wall structure. This study demonstrates the use of a multivalent strategy as an effective way for overcoming such an affinity limitation in bacteria targeting. We designed a series of fifth generation (G5) poly(amidoamine) (PAMAM) dendrimers tethered with vancomycin at the C-terminus at different valencies. We performed surface plasmon resonance (SPR) studies to determine their binding avidity to two cell wall models, each made with either a vancomycin-susceptible (d)-Ala-(d)-Ala or vancomycin-resistant (d)-Ala-(d)-Lac cell wall precursor. These conjugates showed remarkable enhancement in avidity in the cell wall models tested, including the vancomycin-resistant model, which had an increase in avidity of four to five orders of magnitude greater than free vancomycin. The tight adsorption of the conjugate to the model surface corresponded with its ability to bind vancomycin-susceptible Staphylococcus aureus bacterial cells in vitro as imaged by confocal fluorescent microscopy. This vancomycin platform was then used to fabricate the surface of iron oxide nanoparticles by coating them with the dendrimer conjugates, and the resulting dendrimer-covered magnetic nanoparticles were demonstrated to rapidly sequester bacterial cells. In summary, this article investigates the biophysical basis of the tight, multivalent association of dendrimer-based vancomycin conjugates to the bacterial cell wall, and proposes a potential new use of this nanoplatform in targeting Gram-positive bacteria.

Original languageEnglish
Pages (from-to)214-228
Number of pages15
JournalACS Nano
Volume7
Issue number1
DOIs
Publication statusPublished - 22 Jan 2013
Externally publishedYes

Keywords

  • bacterial cell wall
  • iron oxide nanoparticle
  • poly(amidoamine) dendrimer
  • surface plasmon resonance spectroscopy
  • vancomycin

Cite this

Choi, S. K., Myc, A., Silpe, J. E., Sumit, M., Wong, P. T., McCarthy, K., ... Baker, J. R. (2013). Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. ACS Nano, 7(1), 214-228. https://doi.org/10.1021/nn3038995
Choi, Seok Ki ; Myc, Andrzej ; Silpe, Justin Ezekiel ; Sumit, Madhuresh ; Wong, Pamela Tinmoi ; McCarthy, Kelly ; Desai, Ankur M. ; Thomas, Thommey P. ; Kotlyar, Alina ; Holl, Mark M. Banaszak ; Orr, Bradford G. ; Baker, James R. / Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. In: ACS Nano. 2013 ; Vol. 7, No. 1. pp. 214-228.
@article{6b2d808eabb948f295dcbf40fe514c4a,
title = "Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface",
abstract = "Vancomycin represents the preferred ligand for bacteria-targeting nanosystems. However, it is inefficient for emerging vancomycin-resistant species because of its poor affinity to the reprogrammed cell wall structure. This study demonstrates the use of a multivalent strategy as an effective way for overcoming such an affinity limitation in bacteria targeting. We designed a series of fifth generation (G5) poly(amidoamine) (PAMAM) dendrimers tethered with vancomycin at the C-terminus at different valencies. We performed surface plasmon resonance (SPR) studies to determine their binding avidity to two cell wall models, each made with either a vancomycin-susceptible (d)-Ala-(d)-Ala or vancomycin-resistant (d)-Ala-(d)-Lac cell wall precursor. These conjugates showed remarkable enhancement in avidity in the cell wall models tested, including the vancomycin-resistant model, which had an increase in avidity of four to five orders of magnitude greater than free vancomycin. The tight adsorption of the conjugate to the model surface corresponded with its ability to bind vancomycin-susceptible Staphylococcus aureus bacterial cells in vitro as imaged by confocal fluorescent microscopy. This vancomycin platform was then used to fabricate the surface of iron oxide nanoparticles by coating them with the dendrimer conjugates, and the resulting dendrimer-covered magnetic nanoparticles were demonstrated to rapidly sequester bacterial cells. In summary, this article investigates the biophysical basis of the tight, multivalent association of dendrimer-based vancomycin conjugates to the bacterial cell wall, and proposes a potential new use of this nanoplatform in targeting Gram-positive bacteria.",
keywords = "bacterial cell wall, iron oxide nanoparticle, poly(amidoamine) dendrimer, surface plasmon resonance spectroscopy, vancomycin",
author = "Choi, {Seok Ki} and Andrzej Myc and Silpe, {Justin Ezekiel} and Madhuresh Sumit and Wong, {Pamela Tinmoi} and Kelly McCarthy and Desai, {Ankur M.} and Thomas, {Thommey P.} and Alina Kotlyar and Holl, {Mark M. Banaszak} and Orr, {Bradford G.} and Baker, {James R.}",
year = "2013",
month = "1",
day = "22",
doi = "10.1021/nn3038995",
language = "English",
volume = "7",
pages = "214--228",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society (ACS)",
number = "1",

}

Choi, SK, Myc, A, Silpe, JE, Sumit, M, Wong, PT, McCarthy, K, Desai, AM, Thomas, TP, Kotlyar, A, Holl, MMB, Orr, BG & Baker, JR 2013, 'Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface' ACS Nano, vol. 7, no. 1, pp. 214-228. https://doi.org/10.1021/nn3038995

Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface. / Choi, Seok Ki; Myc, Andrzej; Silpe, Justin Ezekiel; Sumit, Madhuresh; Wong, Pamela Tinmoi; McCarthy, Kelly; Desai, Ankur M.; Thomas, Thommey P.; Kotlyar, Alina; Holl, Mark M. Banaszak; Orr, Bradford G.; Baker, James R.

In: ACS Nano, Vol. 7, No. 1, 22.01.2013, p. 214-228.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface

AU - Choi, Seok Ki

AU - Myc, Andrzej

AU - Silpe, Justin Ezekiel

AU - Sumit, Madhuresh

AU - Wong, Pamela Tinmoi

AU - McCarthy, Kelly

AU - Desai, Ankur M.

AU - Thomas, Thommey P.

AU - Kotlyar, Alina

AU - Holl, Mark M. Banaszak

AU - Orr, Bradford G.

AU - Baker, James R.

PY - 2013/1/22

Y1 - 2013/1/22

N2 - Vancomycin represents the preferred ligand for bacteria-targeting nanosystems. However, it is inefficient for emerging vancomycin-resistant species because of its poor affinity to the reprogrammed cell wall structure. This study demonstrates the use of a multivalent strategy as an effective way for overcoming such an affinity limitation in bacteria targeting. We designed a series of fifth generation (G5) poly(amidoamine) (PAMAM) dendrimers tethered with vancomycin at the C-terminus at different valencies. We performed surface plasmon resonance (SPR) studies to determine their binding avidity to two cell wall models, each made with either a vancomycin-susceptible (d)-Ala-(d)-Ala or vancomycin-resistant (d)-Ala-(d)-Lac cell wall precursor. These conjugates showed remarkable enhancement in avidity in the cell wall models tested, including the vancomycin-resistant model, which had an increase in avidity of four to five orders of magnitude greater than free vancomycin. The tight adsorption of the conjugate to the model surface corresponded with its ability to bind vancomycin-susceptible Staphylococcus aureus bacterial cells in vitro as imaged by confocal fluorescent microscopy. This vancomycin platform was then used to fabricate the surface of iron oxide nanoparticles by coating them with the dendrimer conjugates, and the resulting dendrimer-covered magnetic nanoparticles were demonstrated to rapidly sequester bacterial cells. In summary, this article investigates the biophysical basis of the tight, multivalent association of dendrimer-based vancomycin conjugates to the bacterial cell wall, and proposes a potential new use of this nanoplatform in targeting Gram-positive bacteria.

AB - Vancomycin represents the preferred ligand for bacteria-targeting nanosystems. However, it is inefficient for emerging vancomycin-resistant species because of its poor affinity to the reprogrammed cell wall structure. This study demonstrates the use of a multivalent strategy as an effective way for overcoming such an affinity limitation in bacteria targeting. We designed a series of fifth generation (G5) poly(amidoamine) (PAMAM) dendrimers tethered with vancomycin at the C-terminus at different valencies. We performed surface plasmon resonance (SPR) studies to determine their binding avidity to two cell wall models, each made with either a vancomycin-susceptible (d)-Ala-(d)-Ala or vancomycin-resistant (d)-Ala-(d)-Lac cell wall precursor. These conjugates showed remarkable enhancement in avidity in the cell wall models tested, including the vancomycin-resistant model, which had an increase in avidity of four to five orders of magnitude greater than free vancomycin. The tight adsorption of the conjugate to the model surface corresponded with its ability to bind vancomycin-susceptible Staphylococcus aureus bacterial cells in vitro as imaged by confocal fluorescent microscopy. This vancomycin platform was then used to fabricate the surface of iron oxide nanoparticles by coating them with the dendrimer conjugates, and the resulting dendrimer-covered magnetic nanoparticles were demonstrated to rapidly sequester bacterial cells. In summary, this article investigates the biophysical basis of the tight, multivalent association of dendrimer-based vancomycin conjugates to the bacterial cell wall, and proposes a potential new use of this nanoplatform in targeting Gram-positive bacteria.

KW - bacterial cell wall

KW - iron oxide nanoparticle

KW - poly(amidoamine) dendrimer

KW - surface plasmon resonance spectroscopy

KW - vancomycin

UR - http://www.scopus.com/inward/record.url?scp=84872865923&partnerID=8YFLogxK

U2 - 10.1021/nn3038995

DO - 10.1021/nn3038995

M3 - Article

VL - 7

SP - 214

EP - 228

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 1

ER -